Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial

This publication has 19 references indexed in Scilit:

• The Safety and Efficacy of ALLERVAX CAT in Cat Allergic Patients
  Clinical Immunology, 1999
• Grass pollen immunotherapy decreases the number of mast cells in the skin
  Clinical and Experimental Allergy, 1999
• Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats☆☆☆★★★
  Journal of Allergy and Clinical Immunology, 1998
• Role of interleukin 10 in specific immunotherapy.
  Journal of Clinical Investigation, 1998
• Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom☆☆☆★★★
  Journal of Allergy and Clinical Immunology, 1998
• Fel d 1 peptides: effect on skin tests and cytokine synthesis in cat-allergic human subjects
  International Immunology, 1996
• A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells.
  The Journal of Experimental Medicine, 1996
• Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.
  Journal of Clinical Investigation, 1993
• Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes
  Immunology Today, 1993
• IgE Antibody Measurements in Ragweed Hay Fever RELATIONSHIP TO CLINICAL SEVERITY AND THE RESULTS OF IMMUNOTHERAPY
  Journal of Clinical Investigation, 1973